China’s spectacular rise reshapes Asia’s pharma future
The balance of power in the global pharmaceutical industry is shifting east
South Korea: Asia’s second innovation engine
South Korea has been the second most important contributor to the growth of Asian drug innovation
India’s pharma growth has been built on low-cost generics, making it the world’s 11th-largest market by value
Japan mirrors Europe’s pharma challenge, with its share of global drug approvals and clinical trials declining
Makary's successor faces tough task managing FDA amid budget cuts
Trump's 100% pharma tariffs will have a limited effect on the sector
Watch: European pharma's fight to stay relevant
European pharma's fight to stay relevant
Transformative or overhyped? The impact of weight-loss drugs on European food…
Europe’s last chance to revive its pharmaceutical innovation power
Pharma’s Godfather moment: pulled back into tariff uncertainty
Dutch healthcare sector set to expand further despite supply constraints
Higher productivity and a less tight labour market support the growth of healthcare provision in the Netherlands
Listen: Pharma 2026 - higher prices, manufacturing migration, China's…
In this podcast, ING's Diederik Stadig and Stephen Farrelly share their outlook for the drug sector in 2026
Pharma’s 2026 hit list: The White Album
Pharma's 2026 hit list: The White Album
All over the world our analysts write about their dedicated region.
Money (That's What I Want): 2026 is the year of truth for Trump’s…
Hello, Goodbye: Europe loses ground as China becomes powerhouse of innovation
Come Together: Pharma M&A set to accelerate in 2026
Webinar: the pharmaceutical industry's global reset
